Marcia Valenstein. Show Affiliations »
Abstract
Entities: Gene
Mesh: See more » Cyclohexanols/therapeutic useDelayed-Action PreparationsDepressive Disorder, Major/drug therapyDrug Therapy, CombinationHumansLithium/therapeutic useMianserin/analogs & derivativesMianserin/therapeutic useMirtazapinePlacebosResearch DesignTranylcypromine/therapeutic useTreatment OutcomeTriiodothyronine/therapeutic useVenlafaxine Hydrochloride
Substances: See more » CyclohexanolsDelayed-Action PreparationsPlacebosTriiodothyronineMianserinTranylcypromineVenlafaxine HydrochlorideLithiumMirtazapine
Year: 2006 PMID: 16946168 DOI: 10.1176/ajp.2006.163.9.1484
Source DB: PubMed Journal: Am J Psychiatry ISSN: 0002-953X Impact factor: 18.112